BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1460519)

  • 1. Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma.
    Bushnell DL; Boles MA; Kaufman GE; Wadas MA; Barnes WE
    J Nucl Med; 1992 Dec; 33(12):2214-21. PubMed ID: 1460519
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dosimetry of the hematopoietic system in radioiodine therapy of thyroid cancer].
    Günter HH; Junker D; Schober O; Hundeshagen H
    Strahlenther Onkol; 1987 Mar; 163(3):185-91. PubMed ID: 3563879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of radioiodine in management of thyroid cancer: experience with 70 cases.
    Afroz S; Ahmed K; Yasmeen S; Ahmed F; Nisa L
    Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):68-71. PubMed ID: 1303083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience in the management of thyroid carcinoma by I-131. A report of 39 cases.
    Bricout P; Kibler RS
    J Can Assoc Radiol; 1973 Dec; 24(4):323-7. PubMed ID: 4773908
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of 131I in the combined modality therapy of highly differentiated cancer of the thyroid gland].
    Baranauskas ZL; Mamontov VV; Valutskas KK
    Med Radiol (Mosk); 1989 Oct; 34(10):31-4. PubMed ID: 2811625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 131I dosimetry and thyroid stunning.
    Gerard SK; Park HM
    J Nucl Med; 2003 Dec; 44(12):2039-40; author reply 2040. PubMed ID: 14660731
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of high-dosage radioiodine therapy in the elimination of remnant tissue following total thyroidectomy].
    Schümichen C; Bulczak-Schmidt M; Blattmann H; Pauli-Harnasch C
    Nuklearmedizin; 1984 Oct; 23(5):265-9. PubMed ID: 6522276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preleukemia following large dose radioiodide therapy for metastatic thyroid carcinoma.
    Yoosufani Z; Slavin JD; Hellman RM; Sethi SS; Spencer RP
    J Nucl Med; 1987 Aug; 28(8):1348-50. PubMed ID: 3612295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined surgical and radiotherapeutic treatment of papillary and follicular thyroid carcinoma].
    Jadoul D; Glanzmann C; Lütolf U; Hahnloser P
    Helv Chir Acta; 1976 Dec; 43(5-6):635-40. PubMed ID: 826510
    [No Abstract]   [Full Text] [Related]  

  • 11. Radioiodine and radiotherapy in the management of thyroid cancers.
    Simpson WJ
    Otolaryngol Clin North Am; 1990 Jun; 23(3):509-21. PubMed ID: 1694984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effective focal doses and the radiation loads in the radioiodine therapy of thyroid cancer].
    Ivanitskaia VI; Shantyr' VI; Pudovkina LF; Kozhukhov VD
    Med Radiol (Mosk); 1981 Nov; 26(11):6-12. PubMed ID: 7332697
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients.
    Maxon HR; Englaro EE; Thomas SR; Hertzberg VS; Hinnefeld JD; Chen LS; Smith H; Cummings D; Aden MD
    J Nucl Med; 1992 Jun; 33(6):1132-6. PubMed ID: 1597728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodine-131 in breast milk following therapy for thyroid carcinoma.
    Robinson PS; Barker P; Campbell A; Henson P; Surveyor I; Young PR
    J Nucl Med; 1994 Nov; 35(11):1797-801. PubMed ID: 7965159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postsurgical management of differentiated thyroid carcinoma.
    Mazzaferri EL; Robyn J
    Otolaryngol Clin North Am; 1996 Aug; 29(4):637-62. PubMed ID: 8844735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: experience at University of Michigan.
    Beierwaltes WH; Rabbani R; Dmuchowski C; Lloyd RV; Eyre P; Mallette S
    J Nucl Med; 1984 Dec; 25(12):1287-93. PubMed ID: 6502251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone marrow depression due to 131I treatment of thyroid cancer].
    Keldsen N; Mortensen BT; Hansen HS
    Ugeskr Laeger; 1988 Nov; 150(46):2817-9. PubMed ID: 3206692
    [No Abstract]   [Full Text] [Related]  

  • 18. [Radioiodine therapy in differentiated thyroid gland carcinoma].
    Schicha H; Dietlein M
    Zentralbl Chir; 1997; 122(4):266-73. PubMed ID: 9221637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myelodysplastic syndrome following radioiodine treatment of differentiated carcinoma of the thyroid].
    García Pascual L; Simó R; Mesa J; Galofré P
    Rev Clin Esp; 1992 Jul; 191(3):169-70. PubMed ID: 1502411
    [No Abstract]   [Full Text] [Related]  

  • 20. Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.
    Dorn R; Kopp J; Vogt H; Heidenreich P; Carroll RG; Gulec SA
    J Nucl Med; 2003 Mar; 44(3):451-6. PubMed ID: 12621014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.